Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease
Clinical trial NCT02630966 · COMPLETED
Trial details
- NCT number
- NCT02630966
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-10
- Primary completion
- 2018-09-04
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.